3.80Open3.80Pre Close0 Volume1 Open Interest10.00Strike Price0.00Turnover617.49%IV-67.57%PremiumOct 18, 2024Expiry Date6.30Intrinsic Value100Multiplier5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8500Delta0.0887Gamma0.57Leverage Ratio-0.0589Theta-0.0010Rho-0.49Eff Leverage0.0010Vega
Cibus Inc Stock Discussion
Cibus Achieves Positive Initial Field Trial Results for Stacked Gene Edited Herbicide Tolerant Traits in Rice
Cibus (Nasdaq: CBUS) has announced positive initial field trial results for a novel weed management solution in rice using stacked gene edited herbicide tolerant traits. The trials showed that using two herbicides provided excellent weed control. This approach could enable farmers to use a comprehensive weed management system with two different modes of action, p...
$Grove Collaborative (GROV.US)$ 16m float / 74% institutional/ 30% CTB
$Acorda Therapeutics (ACOR.US)$ 1.2m float/ 18% institutional/ 37% CTB
$Verastem (VSTM.US)$ 16m float / 40% institutional/ 18% CTB
$Cibus Inc (CBUS.US)$ 16m float / 12% institutional
$Bone Biologics (BBLG.US)$ 27m float / 17% institutional/ 127% CTB
$Greenlane (GNLN.US)$ 1.5m float/ 17% institutional/ 35% CTB
$VistaGen Therapeutics (VTGN.US)$ 7.2m floa...
No comment yet